Global perspectives on Covid-19 vaccination_Shelly Kamin-Friedman_FINAL.png

Global perspectives on Covid-19 vaccination - Access to the Covid-19 vaccine in Israel

For free

This study is part of the series "No one is safe until everyone is safe - Global perspectives on Covid-19 vaccination" by the Heinrich-Böll-Stiftung's European Union and Washington, DC offices.


The rate of COVID-19 vaccination in Israel is one of the highest in the world. However, vaccine rates are not evenly distributed among the different population groups. Arab citizens and the Ultra-Orthodox population, who have suffered the most from the pandemic, are vaccinated at lower rates than the general public. Moreover, social media disinformation campaigns that have characterized the COVID-19 pandemic in Israel, in general, and the vaccine, in particular, has been one of the causes of vaccine hesitancy.

Product details
Date of Publication
June 2021
Heinrich-Böll-Stiftung European Union and Heinrich-Böll-Stiftung Washington, DC
Number of Pages
Language of publication
Table of contents

State of the COVID-19 pandemic in Israel

Current state of vaccine deployment in the country

BriLife, a vector-based Israeli vaccine

Which vaccines are used and who provides them?

When were COVID-19 vaccines approved in Israel?

Why was a certain vaccine chosen over others?

Are vaccines free of charge for the whole population?

Which timeline will vaccinations follow, and when are vaccines expected to be widely available to the general public?

What are the expected consequences of the vaccine deployment for the economic outlook in Israel?

Cultural and socio-political implications regarding vaccine acceptance

Is vaccination mandatory?

What is the vaccination status of the population with respect to other diseases that might serve as examples?

Is disinformation about vaccines a relevant factor?

Expectations from international actors

How have political alliances played out in the vaccination context?